Background:  Prostaglandin D synthase catalyzes the isomerization of prostaglandin H2 to prostaglandin D2 (PGD2). PGD2 functions as a neuromodulator as well as a trophic factor in the central nervous system. PGD2 is also involved in smooth muscle contraction/relaxation and is a potent inhibitor of platelet aggregation. Two distinct types of prostaglandin D synthase have been identified, namely the lipocalin type enzyme (b trace) and the hematopoietic enzyme. Lipocalin type prostaglandin D synthase is localized in the central nervous system and male genital organs of various mammals and the human heart whereas the hematopoietic prostaglandin D synthase is widely distributed in the peripheral tissues and localized in the antigen presenting cells, mast cells, and megakaryocytes. The lipocalin type prostaglandin D synthase (L-PGDS) has been identified as b trace, which is a major protein in human cerebrospinal fluid.

Description: Rabbit polyclonal to L-PGDS

Immunogen: KLH conjugated synthetic peptide derived from L-PGDS

Specificity:  ·Reacts with Human, Mouse and Rat.

·Isotype: IgG

Application:  ·Western blotting: 1/100-500. Predicted Mol wt: 21 kDa;

·Immunohistochemistry (Frozen/paraffin tissue section): 1/50-200;

·Immunocytochemistry: 1/100;

·Optimal working dilutions must be determined by the end user.